Literature DB >> 23032712

Endoleaks after endovascular abdominal aortic aneurysm repair: what one needs to know.

Felix J V Schlösser1, Bart E Muhs.   

Abstract

PURPOSE OF REVIEW: To review the current state of diagnosis, treatment, and outcomes of the different types of endoleaks after endovascular abdominal aortic aneurysm repair (endovascular aneurysm repair, EVAR). RECENT
FINDINGS: Endoleaks are the most frequent complication after EVAR, the most common indication for secondary interventions, and the most common cause of rupture after EVAR. Imaging is critical for detecting endoleaks. Type I and III endoleaks require urgent intervention to prevent aneurysm rupture. Intervention for other endoleaks or endotension is indicated if the aneurysm sac continues to grow during follow-up. The majority of endoleaks can be treated with endovascular techniques. Open surgical conversion may be considered if the risk of aneurysm rupture is high and if no endovascular options are available or if they have failed.
SUMMARY: Endoleaks continue to be a challenge and this article discusses the different treatment options for endoleaks after EVAR. Long-term follow-up after EVAR is required to diagnose and treat endoleaks before they result in aneurysm rupture. The majority of endoleaks can be treated with endovascular techniques, although open surgical interventions may be required in selected patients.

Entities:  

Mesh:

Year:  2012        PMID: 23032712     DOI: 10.1097/HCO.0b013e3283582fc0

Source DB:  PubMed          Journal:  Curr Opin Cardiol        ISSN: 0268-4705            Impact factor:   2.161


  9 in total

1.  Early and delayed rupture after endovascular abdominal aortic aneurysm repair in a 10-year multicenter registry.

Authors:  Leah Candell; Lue-Yen Tucker; Philip Goodney; Joy Walker; Steven Okuhn; Bradley Hill; Robert Chang
Journal:  J Vasc Surg       Date:  2014-06-21       Impact factor: 4.268

Review 2.  [Complications following aortic reconstruction surgery].

Authors:  E Kleinspehn; F Heidemann; C A Behrendt; T Kölbel; E S Debus
Journal:  Chirurg       Date:  2015-07       Impact factor: 0.955

Review 3.  [Endovascular aortic repair of endoleaks : Diagnosis, treatment, and outcomes].

Authors:  Sven Rudolf Hauck; Rüdiger Schernthaner; Theresa-Marie Dachs; Maximilian Kern; Martin Funovics
Journal:  Radiologie (Heidelb)       Date:  2022-06-23

4.  Metabolic syndrome is associated with type II endoleak after endovascular abdominal aortic aneurysm repair.

Authors:  Michael R Hall; Clinton D Protack; Roland Assi; Willis T Williams; Daniel J Wong; Daniel Lu; Bart E Muhs; Alan Dardik
Journal:  J Vasc Surg       Date:  2013-12-17       Impact factor: 4.268

Review 5.  Novel Molecular Imaging Approaches to Abdominal Aortic Aneurysm Risk Stratification.

Authors:  Jakub Toczek; Judith L Meadows; Mehran M Sadeghi
Journal:  Circ Cardiovasc Imaging       Date:  2016-01       Impact factor: 7.792

Review 6.  Contemporary Management of Abdominal Aortic Aneurysms.

Authors:  Kofi B Quaye; Neena Pack; Timothy Wilson-Byrne; Chandler A Long
Journal:  Curr Cardiol Rep       Date:  2022-02-02       Impact factor: 2.931

7.  Late Sac Rupture due to a Type IV Endoleak after Previous Endovascular Aortic Aneurysm Repair: A Case Report.

Authors:  Konstantinos Filis; Constantinos Zarmakoupis; Georgios Karantzikos; Frangiska Sigala; Gerasimos Bazigos; George Galyfos
Journal:  Front Surg       Date:  2017-08-10

8.  Single-center Study Comparing Short and Mid-Term Results of EVAR in Old and Young Populations.

Authors:  Mihriban Yalcin; Osman Tiryakioglu
Journal:  Braz J Cardiovasc Surg       Date:  2019-06-01

9.  An International, Multicenter Retrospective Observational Study to Assess Technical Success and Clinical Outcomes of Patients Treated with an Endovascular Aneurysm Sealing Device for Type III Endoleak.

Authors:  Aleksandra C Zoethout; Shirley Ketting; Clark J Zeebregts; Dimitri Apostolou; Barend M E Mees; Patrick Berg; Hazem El Beyrouti; Jean-Paul P M De Vries; Francesco Torella; Mattia Migliari; Roberto Silingardi; Michel M P J Reijnen
Journal:  J Endovasc Ther       Date:  2021-08-03       Impact factor: 3.487

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.